Affiliation:
1. College of Medicine, QU Health Qatar University Doha Qatar
2. Department of Medical Education Hamad Medical Corporation (HMC) Doha Qatar
3. Plastic Surgery Department, Hamad General Hospital Hamad Medical Corporation Doha Qatar
Abstract
AbstractOur meta‐analysis aimed to quantify the association between Hidradenitis suppurativa (HS) and several risk factors including obesity, smoking, and type 2 diabetes mellitus (T2DM). We searched PubMed, Scopus, Embase, Web of Science, and cumulative index to nursing and allied health literature for articles reporting either the odds ratio (OR) or the numbers of HS cases associated with obesity, smoking, or T2DM, and including HS negative controls. Risk of bias was assessed against the risk of bias in non‐randomized studies of interventions tool. Data synthesis was done using the random effects model with heterogeneity being evaluated with I2 statistic. Twenty‐three studies with a total of 29 562 087 patients (average age of 36.6 years) were included. Ten studies relied on country‐level data, while six studies collected their data from HS clinics. The analysis showed a significant association between HS and female sex (OR 2.34, 95% CI 1.89–2.90, I2 = 98.6%), DM (OR 2.78, 95% CI 2.23–3.47, I2 = 98.9%), obesity (OR 2.48, 95% CI 1.64–3.74, I2 = 99.9%), and smoking (OR 3.10 95% CI 2.60–3.69, I2 = 97.1%). Our meta‐analysis highlights HS links to sex, DM, obesity, and smoking, with emphasis on holistic management approach. Further research is needed on molecular mechanisms and additional risk factors for improved patient care.
Reference43 articles.
1. BallardK ShumanVL.Hidradenitis Suppurativa. StatPearls. Treasure Island (FL) Ineligible Companies. Disclosure: Victoria Shuman Declares no Relevant Financial Relationships with Ineligible Companies: StatPearls Publishing Copyright © 2023 StatPearls Publishing LLC.2023.
2. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment;Napolitano M;Clinic Cosmetic Investig Dermatol,2017
3. Incidence, risk factors, and prognosis of hidradenitis suppurativa across the globe: insights from the literature;Alotaibi HM;Clinic Cosmet Investig Dermatol,2023
4. Prevalence of hidradenitis suppurativa: a systematic review and meta‐regression analysis;Jfri A;JAMA Dermatol,2021
5. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement;Moher D;PLoS Med,2009